Arcellx (ACLX) Non Operating Income (2021 - 2025)

Arcellx (ACLX) recorded quarterly Non Operating Income of $5.6 million in Q4 2025, down 6.41% quarter-over-quarter from $6.0 million in Q3 2025, and down 25.94% on a YoY basis from $7.6 million in Q4 2024.

Arcellx (ACLX) Non Operating Income (2021 - 2025) Analysis & Trends

Arcellx's Non Operating Income history runs 5 years deep, the most recent figure standing at $5.6 million for Q4 2025.

  • In Q4 2025, Non Operating Income fell 25.94% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at $24.2 million (down 25.0% YoY), while the FY2025 annual figure was $24.2 million, down 25.0% from the prior year.
  • Non Operating Income was $5.6 million for Q4 2025 at Arcellx, down from $6.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $8.6 million in Q1 2024 to a low of $1000.0 in Q1 2021.
  • Historically, Non Operating Income has averaged $3.9 million across 5 years, with a median of $5.4 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Non Operating Income surged 51700.0% in 2022, then slipped 26.41% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $28000.0 in 2021, then soared by 3514.29% to $1.0 million in 2022, then surged by 440.22% to $5.5 million in 2023, then surged by 38.58% to $7.6 million in 2024, then slipped by 25.94% to $5.6 million in 2025.
  • The last three Non Operating Income figures came in at $5.6 million (Q4 2025), $6.0 million (Q3 2025), and $6.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 5.61 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.61 Mn
Sep 30, 2025 6.00 Mn
Jun 30, 2025 5.98 Mn
Mar 31, 2025 6.63 Mn
Dec 31, 2024 7.58 Mn
Sep 30, 2024 7.97 Mn
Jun 30, 2024 8.13 Mn
Mar 31, 2024 8.61 Mn
Dec 31, 2023 5.47 Mn
Sep 30, 2023 5.52 Mn
Jun 30, 2023 5.42 Mn
Mar 31, 2023 3.44 Mn
Dec 31, 2022 1.01 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 518,000.00
Mar 31, 2022 50,000.00
Dec 31, 2021 28,000.00
Sep 30, 2021 19,000.00
Jun 30, 2021 1,000.00
Mar 31, 2021 1,000.00